For Erin Xie, this momentum previews how quickly the disaster could end, and which healthcare companies may continue to innovate for years to come.
Xie has found success investing in companies that produce this type of innovation. On an absolute-return basis that's not compared to any benchmark, her fund emerged on top out of all US-domiciled, open-ended peers that had run for 20 years as of April 30, according to Morningstar data. It returned 14.2% on average over the same timeframe.
It helps in healthcare investing when one has a scientific background. Xie earned a doctorate in biochemistry, and then got interested in the business side when she subsequently bagged an MBA from the Sloan School of Management.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
La source: BusinessInsider - 🏆 729. / 51 Lire la suite »